Section Arrow
GCTK.NASDAQ
- GlucoTrack Inc
(Financial Status)
Quotes are at least 15-min delayed:2025/07/06 17:45 EDT
Last
 6.62
+0.09 (+1.38%)
Day High 
7.3779 
Prev. Close
6.53 
1-M High
15.9 
Volume 
249.49K 
Bid
6.52
Ask
6.83
Day Low
6.3 
Open
6.51 
1-M Low
5.16 
Market Cap 
3.71M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 6.35 
20-SMA 7.07 
50-SMA 8.3 
52-W High 3,756 
52-W Low 5.16 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3,442.80/--
Enterprise Value
3.94M
Balance Sheet
Book Value Per Share
12.79
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
43.49K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor13.88-0.01-0.07%13.36PE
MBOTMicrobot Medical2.6+0.1+4.00%-- 
ALCAlcon87.78-1.52-1.70%39.69PE
XRAYDENTSPLY SIRONA16.67+0.1+0.60%-- 
COOCooper Companies (The)73.3+0.28+0.38%35.28PE
Quotes are at least 15-min delayed:2025/07/06 17:45 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.